Neuromon B.V. is licensed for the implementation of the so-called PaR-technology.

PaR-technology is a new way to express cerebral autoregulatory state by calculating a combined index based upon the continuous registration of arterial blood pressure, as the driving force, and middle cerebral artery flow velocity, as resultant.

The so-called pulsatile apparent resistance is negative when cerebral autoregulation is exhausted. Varies between 0 and 0.6 in the normal situation and increases over 0.6 in intracranial hypertension.

PaR-technology has been filed in the EU, USA, Canada and Australia (WO2005102158A1).

 

EU: EP1755444A1

USA: US2007293760A1

CA: CA2564059A1

AU: AU2005235162A1